110 related articles for article (PubMed ID: 27673323)
21. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
[TBL] [Abstract][Full Text] [Related]
22. ["Spice"--synthetic cannabinoids with dangerous effects].
Personne M; Westerbergh J; Hammer-Pettersen L
Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of cannabinoids.
Grotenhermen F
Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
[TBL] [Abstract][Full Text] [Related]
24. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
Tomiyama K; Funada M
Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid Poisoning by Hemp Seed Oil in a Child.
Chinello M; Scommegna S; Shardlow A; Mazzoli F; De Giovanni N; Fucci N; Borgiani P; Ciccacci C; Locasciulli A; Calvani M
Pediatr Emerg Care; 2017 May; 33(5):344-345. PubMed ID: 27299295
[TBL] [Abstract][Full Text] [Related]
27. Doors of deception: the diaspora of designer drugs.
Kerwin J
Drug Test Anal; 2011 Sep; 3(9):527-31. PubMed ID: 21960538
[No Abstract] [Full Text] [Related]
28. Baths salts, spice, and related designer drugs: the science behind the headlines.
Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
[TBL] [Abstract][Full Text] [Related]
29. Synthetic cannabinoid scares.
Hickey C
JEMS; 2014 Oct; 39(10):14. PubMed ID: 25632498
[No Abstract] [Full Text] [Related]
30. Pediatric fatality review of the 2013 National Poison Database System (NPDS): focus on intent.
Lowry JA; Fine JS; Calello DP; Marcus SM
Clin Toxicol (Phila); 2015 Feb; 53(2):79-81. PubMed ID: 25567685
[No Abstract] [Full Text] [Related]
31. Synthetic cannabinoid use in New Zealand: a recent rebound.
Schep LJ; Slaughter RJ; Temple WA; Lambie BS; Gee P; Watts M; Gresham C
N Z Med J; 2012 Oct; 125(1364):114-6. PubMed ID: 23242407
[No Abstract] [Full Text] [Related]
32. Synthetic cannabinoid use in New Zealand: a brief evaluation of inquiries to the New Zealand National Poisons Centre.
Schep LJ; Slaughter RJ; Temple WA
N Z Med J; 2011 Dec; 124(1347):99-101. PubMed ID: 22237580
[No Abstract] [Full Text] [Related]
33. Designer drugs: a medicinal chemistry perspective.
Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
[TBL] [Abstract][Full Text] [Related]
34. Designer Drugs 2.0.
Huestis MA; Tyndale RF
Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
[TBL] [Abstract][Full Text] [Related]
35. Poisoning in the United States: 2012 emergency medicine report of the National Poison Data System.
Dart RC; Bronstein AC; Spyker DA; Cantilena LR; Seifert SA; Heard SE; Krenzelok EP
Ann Emerg Med; 2015 Apr; 65(4):416-22. PubMed ID: 25523411
[TBL] [Abstract][Full Text] [Related]
36. Clinical Pharmacists: Essential During a Poison Outbreak.
Routsolias JC; Gimbar RP; Zell-Kanter M
J Med Toxicol; 2020 Oct; 16(4):356-357. PubMed ID: 32638283
[No Abstract] [Full Text] [Related]
37. An outbreak of exposure to a novel synthetic cannabinoid.
Monte AA; Bronstein AC; Cao DJ; Heard KJ; Hoppe JA; Hoyte CO; Iwanicki JL; Lavonas EJ
N Engl J Med; 2014 Jan; 370(4):389-90. PubMed ID: 24450915
[No Abstract] [Full Text] [Related]
38. Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210.
Dalton VS; Zavitsanou K
Synapse; 2010 Nov; 64(11):845-54. PubMed ID: 20842718
[TBL] [Abstract][Full Text] [Related]
39. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
Ammann J; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
[TBL] [Abstract][Full Text] [Related]
40. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
